Gossamer Bio, Inc. (GOSS) earnings
Quarterly results of Gossamer Bio, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Gossamer Bio, Inc. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Gossamer Bio, Inc. reported revenue of $9.2M (-19.6% on the same quarter a year earlier) and net income of $16.9M.
Diluted earnings per share were -$0.08.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $9.2M | -19.6% | $16.9M | -$0.08 |
| Q1 FY2026 | $17M | +71.5% | -$46.7M | -$0.20 |
| Q4 FY2025 | $13.8M | +47.1% | -$47.2M | - |
| Q3 FY2025 | $13.3M | +40.2% | -$48.2M | -$0.21 |
| Q2 FY2025 | $11.5M | - | -$38.3M | -$0.17 |
| Q1 FY2025 | $9.9M | - | -$36.6M | -$0.16 |
| Q4 FY2024 | $9.4M | - | -$33M | - |
| Q3 FY2024 | $9.5M | - | -$30.8M | -$0.14 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Gossamer Bio, Inc.'s next earnings date?
Gossamer Bio, Inc. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
What were Gossamer Bio, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Gossamer Bio, Inc. reported revenue of $9.2M and net income of $16.9M. The figures come from its filing with the SEC.
Is Gossamer Bio, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $9.2M, down 19.6% from $11.5M in the same quarter a year earlier.
Get an email when GOSS reports
Follow GOSS and we email you its next results the day they are filed, with the numbers explained.